SURMOUNTING WITHDRAWAL TO INITIATE FAST TREATMENT WITH NALTREXONE (CTN-0097). DSC5 CONTRACT. 09/20/2019 - 11/23/2021. N01DA-19-2250.
$1,251,569N01FY2019DANIH
The Emmes Company, Llc, Rockville MD
Investigators
Abstract
SURMOUNTING WITHDRAWAL TO INITIATE FAST TREATMENT WITH NALTREXONE (CTN-0097).
View original record on NIH RePORTER →